Selective recognition of oligomeric HIV-1 primary isolate envelope glycoproteins by potently neutralizing ligands requires efficient precursor cleavage

Virology

Volumn 332, Issue 1, 2005, Pages 145-156

  Pancera, Marie ^a   Wyatt, Richard ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Glycoproteins; HIV 1; Precursor cleavage

Indexed keywords

CD4 ANTIGEN; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 160; GLYCOPROTEIN GP 41; NEUTRALIZING ANTIBODY; OLIGOMER; PROTEIN PRECURSOR;

ANTIGEN BINDING; ARTICLE; BIOTINYLATION; CELL SURFACE; CONTROLLED STUDY; CORRELATION ANALYSIS; GENETIC TRANSFECTION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN ISOLATION; VIRUS NEUTRALIZATION;

ANTIGENS, VIRAL; CELL LINE; GLYCOPROTEINS; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP160; HIV-1; LIGANDS; NEUTRALIZATION TESTS; RECOMBINANT FUSION PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 12344264596     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.10.042     Document Type: Article

References (63)

1. S.W. Barnett, S. Lu, I. Srivastava, S. Cherpelis, A. Gettie, J. Blanchard, S. Wang, I. Mboudjeka, L. Leung, Y. Lian, A. Fong, C. Buckner, A. Ly, S. Hilt, J. Ulmer, C.T. Wild, J.R. Mascola, and L. Stamatatos The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region J. Virol. 75 12 2001 5526 5540
2. C. Berlioz-Torrent, B.L. Shacklett, L. Erdtmann, L. Delamarre, I. Bouchaert, P. Sonigo, M.C. Dokhelar, and R. Benarous Interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adaptor complexes modulate intracellular and cell-surface expression of envelope glycoproteins J. Virol. 73 2 1999 1350 1361
3. J.M. Binley, R.W. Sanders, B. Clas, N. Schuelke, A. Master, Y. Guo, F. Kajumo, D.J. Anselma, P.J. Maddon, W.C. Olson, and J.P. Moore A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure J. Virol. 74 2 2000 627 643
4. J.M. Binley, R.W. Sanders, A. Master, C.S. Cayanan, C.L. Wiley, L. Schiffner, B. Travis, S. Kuhmann, D.R. Burton, S.L. Hu, W.C. Olson, and J.P. Moore Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins J. Virol. 76 6 2002 2606 2616
5. V. Bosch, and M. Pawlita Mutational analysis of the human immunodeficiency virus type 1 env gene product proteolytic cleavage site J. Virol. 64 5 1990 2337 2344
6. D.R. Burton, J. Pyati, R. Koduri, S.J. Sharp, G.B. Thornton, P.W. Parren, L.S. Sawyer, R.M. Hendry, N. Dunlop, and P.L. Nara Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody Science 266 5187 1994 1024 1027
7. R.J. Center, R.D. Leapman, J. Lebowitz, L.O. Arthur, P.L. Earl, and B. Moss Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surface J. Virol. 76 15 2002 7863 7867
8. B.K. Chakrabarti, W.P. Kong, B.Y. Wu, Z.Y. Yang, J. Friborg, X. Ling, S.R. King, D.C. Montefiori, and G.J. Nabel Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization J. Virol. 76 11 2002 5357 5368
9. J. Chen, K.H. Lee, D.A. Steinhauer, D.J. Stevens, J.J. Skehel, and D.C. Wiley Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation Cell 95 3 1998 409 417
10. L. Chen, J.J. Gorman, J. McKimm-Breschkin, L.J. Lawrence, P.A. Tulloch, B.J. Smith, P.M. Colman, and M.C. Lawrence The structure of the fusion glycoprotein of Newcastle disease virus suggests a novel paradigm for the molecular mechanism of membrane fusion Structure (Camb.) 9 3 2001 255 266
11. E. Chertova, J.W. Bess Jr., B.J. Crise, I.R. Sowder, T.M. Schaden, J.M. Hilburn, J.A. Hoxie, R.E. Benveniste, J.D. Lifson, L.E. Henderson, and L.O. Arthur Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU). Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus J. Virol. 76 11 2002 5315 5325
12. H. Choe, M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P.D. Ponath, L. Wu, C.R. Mackay, G. LaRosa, W. Newman, N. Gerard, C. Gerard, and J. Sodroski The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates Cell 85 7 1996 1135 1148
13. A.G. Dalgleish, P.C. Beverley, P.R. Clapham, D.H. Crawford, M.F. Greaves, and R.A. Weiss The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus Nature 312 5996 1984 763 767
14. H. Deng, R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R.E. Sutton, C.M. Hill, C.B. Davis, S.C. Peiper, T.J. Schall, D.R. Littman, and N.R. Landau Identification of a major co-receptor for primary isolates of HIV-1 Nature 381 6584 1996 661 666
15. J.W. Dubay, S.R. Dubay, H.J. Shin, and E. Hunter Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein: requirement of precursor cleavage for glycoprotein incorporation J. Virol. 69 8 1995 4675 4682
16. P.L. Earl, W. Sugiura, D.C. Montefiori, C.C. Broder, S.A. Lee, C. Wild, J. Lifson, and B. Moss Immunogenicity and protective efficacy of oligomeric human immunodeficiency virus type 1 gp140 J. Virol. 75 2 2001 645 653
17. T.R. Fouts, J.M. Binley, A. Trkola, J.E. Robinson, and J.P. Moore Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex J. Virol. 71 4 1997 2779 2785
18. D.L. Gibbons, M.C. Vaney, A. Roussel, A. Vigouroux, B. Reilly, J. Lepault, M. Kielian, and F.A. Rey Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus Nature 427 6972 2004 320 325
19. C. Grundner, T. Mirzabekov, J. Sodroski, and R. Wyatt Solid-phase proteoliposomes containing human immunodeficiency virus envelope glycoproteins J. Virol. 76 7 2002 3511 3521
20. H.G. Guo, F.M. Veronese, E. Tschachler, R. Pal, V.S. Kalyanaraman, R.C. Gallo, and M.S. Reitz Jr. Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage Virology 174 1 1990 217 224
21. S. Hallenberger, V. Bosch, H. Angliker, E. Shaw, H.D. Klenk, and W. Garten Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160 Nature 360 6402 1992 358 361
22. D. Healey, L. Dianda, J.P. Moore, J.S. McDougal, M.J. Moore, P. Estess, D. Buck, P.D. Kwong, P.C. Beverley, and Q.J. Sattentau Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding J. Exp. Med. 172 4 1990 1233 1242
23. C. Herrera, C. Spenlehauer, M.S. Fung, D.R. Burton, S. Beddows, and J.P. Moore Nonneutralizing antibodies to the CD4-binding site on the gp120 subunit of human immunodeficiency virus type 1 do not interfere with the activity of a neutralizing antibody against the same site J. Virol. 77 2 2003 1084 1091
24. C. Herrera, E. Michael, K. Barnes, Z. Si, J. Sodroski, J.P. Moore, and S. Beddows Consequences of HIV-1 env cleavage on antigenicity, infectivity, and neutralization Abstract Book, Keystone 2004 2004
25. J.M. Kenney, M. Sjoberg, H. Garoff, and S.D. Fuller Visualization of fusion activation in the Semliki Forest virus spike Structure 2 9 1994 823 832
26. J.H. Kim, P. Pitisuttithum, C. Kamboonruang, T. Chuenchitra, J. Mascola, S.S. Frankel, M.S. DeSouza, V. Polonis, R. McLinden, A. Sambor, A.E. Brown, B. Phonrat, K. Rungruengthanakit, A.M. Duliege, M.L. Robb, J. McNeil, and D.L. Birx Specific antibody responses to vaccination with bivalent CM235/SF2 gp120: detection of homologous and heterologous neutralizing antibody to subtype E (CRF01.AE) HIV type 1 AIDS Res. Hum. Retroviruses 19 9 2003 807 816
27. M. Koch, M. Pancera, P.D. Kwong, P. Kolchinsky, C. Grundner, L. Wang, W.A. Hendrickson, J. Sodroski, and R. Wyatt Structure-based, targeted deglycosylation of HIV-1 gp120 and effects on neutralization sensitivity and antibody recognition Virology 313 2 2003 387 400
28. B. Korber, F. Foley, C. Kuiken, S. Pillai, and J. Sodroski Numbering positions in HIV relative to HXBc2 J. Sodroski Human Retroviruses and AIDS 1998 Los Alamos National Laboratory Los Alamos, NM iii-102 iii-103
29. H.G. Krausslich, C. Ochsenbauer, A.M. Traenckner, K. Mergener, M. Facke, H.R. Gelderblom, and V. Bosch Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase Virology 192 2 1993 605 617
30. C.C. LaBranche, M.M. Sauter, B.S. Haggarty, P.J. Vance, J. Romano, T.K. Hart, P.J. Bugelski, M. Marsh, and J.A. Hoxie A single amino acid change in the cytoplasmic domain of the simian immunodeficiency virus transmembrane molecule increases envelope glycoprotein expression on infected cells J. Virol. 69 9 1995 5217 5227
31. J.R. Mascola, M.K. Louder, C. Winter, R. Prabhakara, S.C. De Rosa, D.C. Douek, B.J. Hill, D. Gabuzda, and M. Roederer Human immunodeficiency virus type 1 neutralization measured by flow cytometric quantitation of single-round infection of primary human T cells J. Virol. 76 10 2002 4810 4821
32. J.M. McCune, L.B. Rabin, M.B. Feinberg, M. Lieberman, J.C. Kosek, G.R. Reyes, and I.L. Weissman Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus Cell 53 1 1988 55 67
33. J.P. Moore, and J. Sodroski Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein J. Virol. 70 3 1996 1863 1872
34. T.G. Morrison Structure and function of a paramyxovirus fusion protein Biochim. Biophys. Acta 1614 1 2003 73 84
35. R. Pantophlet, I.A. Wilson, and D.R. Burton Hyperglycosylated mutants of human immunodeficiency virus (HIV) type 1 monomeric gp120 as novel antigens for HIV vaccine design J. Virol. 77 10 2003 5889 5901
36. P.W. Parren, D.R. Burton, and Q.J. Sattentau HIV-1 antibody-debris or virion? Nat. Med. 3 4 1997 366 367
37. P.W. Parren, I. Mondor, D. Naniche, H.J. Ditzel, P.J. Klasse, D.R. Burton, and Q.J. Sattentau Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity J. Virol. 72 5 1998 3512 3519
38. P. Poignard, M. Moulard, E. Golez, V. Vivona, M. Franti, S. Venturini, M. Wang, P.W. Parren, and D.R. Burton Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies J. Virol. 77 1 2003 353 365
39. M.R. Posner, L.A. Cavacini, C.L. Emes, J. Power, and R. Byrn Neutralization of HIV-1 by F105, a human monoclonal antibody to the CD4 binding site of gp120 J. Acquired Immune. Defic. Syndr. 6 1 1993 7 14
40. P. Roben, J.P. Moore, M. Thali, J. Sodroski, C.F. Barbas 3rd, and D.R. Burton Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1 J. Virol. 68 8 1994 4821 4828
41. R.W. Sanders, M. Venturi, L. Schiffner, R. Kalyanaraman, H. Katinger, K.O. Lloyd, P.D. Kwong, and J.P. Moore The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120 J. Virol. 76 14 2002 7293 7305
42. R.W. Sanders, M. Vesanen, N. Schuelke, A. Master, L. Schiffner, R. Kalyanaraman, M. Paluch, B. Berkhout, P.J. Maddon, W.C. Olson, M. Lu, and J.P. Moore Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1 J. Virol. 76 17 2002 8875 8889
43. Q.J. Sattentau, and J.P. Moore Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer J. Exp. Med. 182 1 1995 185 196
44. C.N. Scanlan, R. Pantophlet, M.R. Wormald, E.O. Saphire, D. Calarese, R. Stanfield, I.A. Wilson, H. Katinger, R.A. Dwek, D.R. Burton, and P.M. Rudd The carbohydrate epitope of the neutralizing anti-HIV-1 antibody 2G12 Adv. Exp. Med. Biol. 535 2003 205 218
45. N. Schulke, M.S. Vesanen, R.W. Sanders, P. Zhu, M. Lu, D.J. Anselma, A.R. Villa, P.W. Parren, J.M. Binley, K.H. Roux, P.J. Maddon, J.P. Moore, and W.C. Olson Oligomeric and conformational properties of a proteolytically mature, disulfide-stabilized human immunodeficiency virus type 1 gp140 envelope glycoprotein J. Virol. 76 15 2002 7760 7776
46. Z. Si, M. Cayabyab, and J. Sodroski Envelope glycoprotein determinants of neutralization resistance in a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) derived by passage in monkeys J. Virol. 75 9 2001 4208 4218
47. Z. Si, N. Phan, E. Kiprilov, and J. Sodroski Effects of HIV type 1 envelope glycoprotein proteolytic processing on antigenicity AIDS Res. Hum. Retroviruses 19 3 2003 217 226
48. J.J. Skehel, and D.C. Wiley Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin Annu. Rev. Biochem. 69 2000 531 569
49. I.K. Srivastava, L. Stamatatos, E. Kan, M. Vajdy, Y. Lian, S. Hilt, L. Martin, C. Vita, P. Zhu, K.H. Roux, L. Vojtech, D.C. Montefiori, J. Donnelly, J.B. Ulmer, and S.W. Barnett Purification, characterization, and immunogenicity of a soluble trimeric envelope protein containing a partial deletion of the V2 loop derived from SF162, an R5-tropic human immunodeficiency virus type 1 isolate J. Virol. 77 20 2003 11244 11259
50. I.K. Srivastava, K. VanDorsten, L. Vojtech, S.W. Barnett, and L. Stamatatos Changes in the immunogenic properties of soluble gp140 human immunodeficiency virus envelope constructs upon partial deletion of the second hypervariable region J. Virol. 77 4 2003 2310 2320
51. L. Stamatatos, M. Lim, and C. Cheng-Mayer Generation and structural analysis of soluble oligomeric gp140 envelope proteins derived from neutralization-resistant and neutralization-susceptible primary HIV type 1 isolates AIDS Res. Hum. Retroviruses 16 10 2000 981 994
52. N. Sullivan, Y. Sun, J. Li, W. Hofmann, and J. Sodroski Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates J. Virol. 69 7 1995 4413 4422
53. A. Trkola, M. Purtscher, T. Muster, C. Ballaun, A. Buchacher, N. Sullivan, K. Srinivasan, J. Sodroski, J.P. Moore, and H. Katinger Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1 J. Virol. 70 2 1996 1100 1108
54. W. Weissenhorn, A. Dessen, S.C. Harrison, J.J. Skehel, and D.C. Wiley Atomic structure of the ectodomain from HIV-1 gp41 Nature 387 6631 1997 426 430
55. R.L. Willey, J.S. Bonifacino, B.J. Potts, M.A. Martin, and R.D. Klausner Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160 Proc. Natl. Acad. Sci. U.S.A. 85 24 1988 9580 9584
56. L. Wu, N.P. Gerard, R. Wyatt, H. Choe, C. Parolin, N. Ruffing, A. Borsetti, A.A. Cardoso, E. Desjardin, W. Newman, C. Gerard, and J. Sodroski CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5 Nature 384 6605 1996 179 183
57. S.H. Xiang, P.D. Kwong, R. Gupta, C.D. Rizzuto, D.J. Casper, R. Wyatt, L. Wang, W.A. Hendrickson, M.L. Doyle, and J. Sodroski Mutagenic stabilization and/or disruption of a CD4-bound state reveals distinct conformations of the human immunodeficiency virus type 1 gp120 envelope glycoprotein J. Virol. 76 19 2002 9888 9899
58. X. Yang, L. Florin, M. Farzan, P. Kolchinsky, P.D. Kwong, J. Sodroski, and R. Wyatt Modifications that stabilize human immunodeficiency virus envelope glycoprotein trimers in solution J. Virol. 74 10 2000 4746 4754
59. X. Yang, R. Wyatt, and J. Sodroski Improved elicitation of neutralizing antibodies against primary human immunodeficiency viruses by soluble stabilized envelope glycoprotein trimers J. Virol. 75 3 2001 1165 1171
60. X. Yang, J. Lee, E.M. Mahony, P.D. Kwong, R. Wyatt, and J. Sodroski Highly stable trimers formed by human immunodeficiency virus type 1 envelope glycoproteins fused with the trimeric motif of T4 bacteriophage fibritin J. Virol. 76 9 2002 4634 4642
61. J. York, K.E. Follis, M. Trahey, P.N. Nyambi, S. Zolla-Pazner, and J.H. Nunberg Antibody binding and neutralization of primary and T-cell line-adapted isolates of human immunodeficiency virus type 1 J. Virol. 75 6 2001 2741 2752
62. C.W. Zhang, Y. Chishti, R.E. Hussey, and E.L. Reinherz Expression, purification, and characterization of recombinant HIV gp140. The gp41 ectodomain of HIV or simian immunodeficiency virus is sufficient to maintain the retroviral envelope glycoprotein as a trimer J. Biol. Chem. 276 43 2001 39577 39585
63. P. Zhu, E. Chertova, J. Bess Jr., J.D. Lifson, L.O. Arthur, J. Liu, K.A. Taylor, and K.H. Roux Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions Proc. Natl. Acad. Sci. U.S.A. 100 26 2003 15812 15817